Диссертация (1140800), страница 19
Текст из файла (страница 19)
/ Labro M.T. // Curr. Pharm. Des. 2004;10(25):3067-80.194. Labro M.T. Macrolide antibiotics: current and future uses / Labro M.T.//Expert. Opin . Pharmacother. 2004 Mar;5(3):541-50.195. Labro M.T. Interaction of the new ketolide ABT-773 (cethromycin) withhuman polymorphonuclear neutrophils and the phagocytic cell line PLB-985 invitro / Labro M.T., Abdelghaffar H., Babin-Chevaye C.// Antimicrob. AgentsChemother. 2004 Apr; 48(4):1096-104.196. Laidlaw T.M. Platelets in patients with aspirin-exacerbated respiratorydisease /Laidlaw T.M., Boyce J.A.//J. Allergy Clin. Immunol.
2015Jun;135(6):1407-14197. Larsen P.L. Origin of nasal polyps: an endoscopic autopsy study./ LarsenP.L., Tos M.// Laryngoscope. 2004 Apr;114(4):710-9.198. Martinez Molina D. Structural basis for synthesis of inflammatory mediatorsby human leukotriene C4 synthase / Martinez Molina D., Wetterholm A., KohlA., McCarthy A.A., Niegowski D., Ohlson E., Hammarberg T., Eshaghi S.,Haeggstrоm J.Z., Nordlund P. // Nature. 2007 Aug 2; 448(7153):613-6.199. Meltzer E.O. Intranasal steroids: managing allergic rhinitis and tailoringtreatment to patient preference / Meltzer E.O.
//Allergy Asthma Proc. 2005Nov-Dec; 26(6):445-51.200. Miller A.L. Chemokine receptors: understanding their role in asthmaticdisease / Miller A.L., Lukacs N.W. // Immunol. Allergy Clin. North Am. 2004Nov; 24(4):667-83.201. Newton J.R. A review of nasal polyposis /Newton J.R., Ah-See K.W. //Ther. Clin. Risk. Manag. 2008 Apr;4(2):507-12.202. Ogunleye A.O. Radiological changes and complications associated withnasal polyposis /Ogunleye A.O., Fasunla A.J.// West Afr.
J. Med. 2004 AprJun;23(2):111-3.203. Ottaviano G.Endoglin (CD105) expression in sinonasal polyposis. /Ottaviano G., Cappellesso R., Mylonakis I., Lionello M., Favaretto N.,131Giacomelli L., Spoladore C., Marchese-Ragona R., Marino F., Staffieri A.,Martini A., Marioni G.// Eur. Arch. Otorhinolaryngol. 2015 Nov; 272(11):3367-73.204. Parnes S.M. Acute effects of antileukotrienes on sinonasal polyposis andsinusitis / Parnes S.M, Chuma A.V. // Ear Nose Throat J. 2000 Jan;79(1):18-20,24-5205. Pauli C.
Polyposis nasi-improvement in quality of life by the influence ofleukotrien receptor antagonists /Pauli C., Fintelmann R., Klemens C., HilgertE., Jund F., Rasp G., Hagedorn H., Kramer M.F. // Laryngorhinootologie. 2007Apr; 86(4):282-6.206. Pelikan Z. Asthmatic response induced by nasal challenge with allergen /Pelikan Z. // Int. Arch.
Allergy Immunol. 2009; 148(4):330-8.207. Peters-Golden M. Leukotrienes / Peters-Golden M, Henderson W.R Jr.// N.Engl. J. Med. 2007 Nov 1;357(18):1841-54.208. Ponikau J.U. The diagnosis and incidence of allergic fungal sinusitis /Ponikau J.U., Sherris D.A., Kern E.B., Homburger H.A., Frigas E., GaffeyT.A., Roberts G.D. // Mayo Clin.
Proc. 1999 Sep; 74(9):877-84.209. Поллард Дж. Справочник по вычислительным методам статистики. –М.: Финансы и статистика, 1982.210. Ragab S. An open audit of montelukast, a leukotriene receptor antagonist, innasal polyposis associated with asthma./ Ragab S., Parikh A., Darby Y.C.,Scadding G.K.// Clin. Exp. Allergy. 2001 Sep; 31(9):1385-91.211. Rasp G. Is there a role for leukotriene antagonists in the prevention ofrecurrent nasal polyps? /Rasp G.// Curr.Opin.Allergy Clin. Immunol.
2010Jun;10(3):200-5.212. Reiss M. Conservative therapy of chronic sinusitis /Reiss M., Reiss G.//Med. Monatsschr. Pharm. 2012 Jan; 35(1):4-12.213. Rix I. Management of chronic rhinosinusitis with nasal polyps andcoexisting asthma: A systematic review / Rix I., Hаkansson K., Larsen C.G.,Frendо M., von Buchwald C. // Am. J. Rhinol.
Allergy. 2015 MayJun;29(3):193-201.132214. Roca-Ferrer J. Proinflammatory cytokines and eosinophil cationic protein onglandular secretion from human nasal mucosa: regulation by corticosteroids. /Roca-Ferrer J., Mullol J., Xaubet A., Benitez P., Bernal-Sprekelsen M.,Shelhamer J., Picado C.// J. Allergy Clin. Immunol. 2001 Jul;108(1):87-93.215.
Roca-Ferrer J. Low prostaglandin E2 and cyclooxygenase expression innasal mucosa fibroblasts of aspirin-intolerant asthmatics / Roca-Ferrer J., PerezGonzalez M., Garcia-Garcia F.J., Pereda J., Pujols L., Alobid I., Mullol J.,Picado C. // Respirology. 2013 May;18(4):711-7.216. Ройт А.
Иммунология/ Ройт А., Бростофф Дж., Мейл Д. // Пер с англ. –М.: Мир, 2000. 592 с.217. Rowe-Jones J.M. Functional endoscopic sinus surgery: 5 year follow up andresults of a prospective, randomised, stratified, double-blind, placebo controlledstudy of postoperative fluticasone propionate aqueous nasal spray / Rowe-JonesJ.M., Medcalf M., Durham S.R., Richards D.H., Mackay I.S. // Rhinology.2005 Mar; 43(1):2-10.218. Rudmik L. Medical Therapies for Adult Chronic Sinusitis: A SystematicReview / Rudmik L., Soler Z.M.
// JAMA. 2015 Sep 1;314(9):926-39219. Sato E. Erythromycin modulates eosinophil chemotactic cytokine productionby human lung fibroblasts in vitro / Sato E., Nelson D.K., Koyama S., HoytJ.C., Robbins R.A. // Antimicrob. Agents Chemother. 2001 Feb;45(2):401-6.220. Schаper C. Anti-inflammatory properties of montelukast, a leukotrienereceptor antagonist in patients with asthma and nasal polyposis / Schаper C.,Noga O., Koch B., Ewert R., Felix S.B., Glаser S., Kunkel G., Gustavus B. // J.Investig Allergol. Clin.
Immunol. 2011; 21(1):51-8.221. Small C.B. Efficacy and safety of mometasone furoate nasal spray in nasalpolyposis / Small C.B., Hernandez J., Reyes A., Schenkel E., Damiano A.,Stryszak P., Staudinger H., Danzig M. // J. Allergy Clin. Immunol. 2005 Dec;116(6):1275-81.222.
Stjаrne P. A randomized controlled trial of mometasone furoate nasal sprayfor the treatment of nasal polyposis / Stjаrne P., Mоsges R., Jorissen M., PassаliD., Bellussi L., Staudinger H., Danzig M. // Arch. Otolaryngol. Head NeckSurg. 2006 Feb;132(2):179-85.133223. Stjаrne P. The efficacy and safety of once-daily mometasone furoate nasalspray in nasal polyposis: a randomized, double-blind, placebo-controlled study /Stjаrne P., Blomgren K., Cayе-Thomasen P., Salo S., Sоderstrоm T. // ActaOtolaryngol. 2006 Jun;126(6):606-12.224. Stewart R.A.
Montelukast as an adjunct to oral and inhaled steroid therapy inchronic nasal polyposis / Stewart R.A., Ram B., Hamilton G., Weiner J., KaneK.J. // Otolaryngol. Head Neck Surg. 2008 Nov;139(5):682-7225. Vuralkan E. Comparison of montelukast and mometasone furoate in theprevention of recurrent nasal polyps / Vuralkan E., Saka C., Akin I.,Hucumenoglu S., Unal B.U., Kuran G., Ocal B. // Ther. Adv. Respir.
Dis. 2012Feb;6(1):5-10.226. Wentzel J.L. Leukotriene antagonists in nasal polyposis: a meta-analysis andsystematic review / Wentzel J.L., Soler Z.M., DeYoung K., Nguyen S.A., LohiaS., Schlosser R.J. // Am. J. Rhinol. Allergy. 2013 Nov-Dec;27(6):482-9.227. Yazıcı Z.M. Effect of montelukast on quality of life in subjects with nasalpolyposis accompanying bronchial asthma. / Yazıcı Z.M., Sayın I., Bozkurt E.,Kayhan F.T.
//Kulak Burun Bogaz Ihtis Derg. 2011 Jul-Aug; 21(4):210-4..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
